During the past decade, Universitätsklinikum Erlangen; Augenklinik conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Erlangen; Augenklinik" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "Lux Biosciences, Inc." with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "University Eye Hospital, Freiburg" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Erlangen; Augenklinik" are "Melanoma (Skin)" (2 trials), "Alzheimer's Disease" (1 trials), "Cornea Transplant" (1 trials), "Corneal Diseases" (1 trials) and "Corneal Graft Rejection" (1 trials). Many other conditions were trialed in "Universitätsklinikum Erlangen; Augenklinik" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Erlangen; Augenklinik" are "Drug" (6 trials), "Other" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "LX201" (2 trials), "Placebo" (2 trials), "Atropine eye drops, 0.01%" (1 trials), "Atropine eye drops, 0.02%" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Erlangen; Augenklinik" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Erlangen; Augenklinik". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitätsklinikum Erlangen; Augenklinik, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Erlangen; Augenklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".